Alvotech
The QC Bioassay Principal Scientist will lead and execute cell‑based potency assays for biosimilar quality control, ensuring compliance with GMP and regulatory standards while troubleshooting and documenting results. The role also involves preparing protocols, supporting reagent qualification, and contributing to regulatory submissions and technology transfer activities.
We specialize in making biosimilars - to improve lives by expanding access to affordable biologic medicines.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alvotech.
Alvotech didn’t post a salary, so this is our estimate from similar listings.
41% above the average for this role
Alvotech to Announce Q4 and Full Year 2025 Financial Results on March 18, 2026
1 week ago
Scientist I Bioassay (AS/QC)
Omeros
Director, Bioassay Development
Denali Therapeutics
Senior Advisor, Bioassay Development — Analytical Development
Eli Lilly and Company
Cell Potency Analytical Development Lead
Artiva Biotherapeutics
QC Analyst - Bioassay
Regeneron Pharmaceuticals
Coop - Bioassay Development
Leica Biosystems